926 F.3d 959
8th Cir.2019Background
- Sanford Health sought to acquire Mid Dakota Clinic; combined would control extremely high shares of four physician service markets in Bismarck‑Mandan (general surgery ~99.8%; pediatrics ~98.6%; adult primary care ~85.7%; OB/GYN ~84.6%).
- FTC and North Dakota AG sued under §7 of the Clayton Act and obtained a preliminary injunction after a four‑day evidentiary hearing; district court found plaintiffs likely to succeed on the merits.
- The district court defined four product markets (adult PCP, pediatrics, OB/GYN, general surgery) and the geographic market as Bismarck‑Mandan using the hypothetical monopolist test, supported by insurer testimony and claims data.
- The court relied on HHI increases well above Merger Guidelines thresholds to find a strong prima facie case that the merger would substantially lessen competition.
- Defendants asserted four principal defenses: (1) concentration ≠ bargaining power due to dominant insurer (Blue Cross) statewide pricing; (2) Catholic Health would enter to restore competition; (3) merger efficiencies and quality improvements would benefit consumers; (4) Mid Dakota was a weakened competitor justifying the sale.
- The district court rejected those defenses (found Blue Cross could be forced to accept worse terms post‑merger, entry by Catholic Health would not be timely/sufficient, most efficiencies were not merger‑specific, and Mid Dakota was not a failing firm) and issued the injunction; this court affirmed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Proper burden framework for preliminary injunction evaluating §7 claim | Use Baker Hughes burden‑shifting; FTC retains burden of persuasion | District court improperly shifted ultimate burden to defendants by quoting Philadelphia Natl. Bank language | Affirmed: court applied Baker Hughes; plaintiffs retained burden; stronger prima facie case required stronger rebuttal evidence |
| Market definition (product/geography) | Four physician service markets in Bismarck‑Mandan are proper; insurers would not drop those services from networks | Market broader because dominant insurer (Blue Cross) would prevent price increases | Affirmed: hypothetical monopolist test supported by insurer testimony and data; no functional substitutes existed |
| Effect of market concentration / buyer power defense | High HHI changes predict increased market power and bargaining leverage | Blue Cross statewide pricing makes concentration irrelevant; no ability to extract higher reimbursements | Affirmed: evidence showed merged Sanford could pressure Blue Cross and concentration related to bargaining leverage |
| Entry, efficiencies, and weakened‑competitor claims | Entry by Catholic Health and merger efficiencies would prevent harm; Mid Dakota was financially weak | Entry not timely/sufficient; most efficiencies not merger‑specific; Mid Dakota was financially healthy | Affirmed: entry unlikely to be timely/sufficient; only one merger‑specific program identified; Mid Dakota not a failing firm |
Key Cases Cited
- United States v. Baker Hughes Inc., 908 F.2d 981 (D.C. Cir. 1990) (endorses burden‑shifting prima facie framework for merger challenges)
- United States v. Philadelphia Nat'l Bank, 374 U.S. 321 (1963) (mergers producing undue market shares are presumptively anticompetitive absent clear evidence to the contrary)
- FTC v. Tenet Health Care Corp., 186 F.3d 1045 (8th Cir. 1999) (injunction analysis weighs equities and likelihood of FTC success under §53(b))
- Saint Alphonsus Med. Ctr.-Nampa Inc. v. St. Luke’s Health Sys., Ltd., 778 F.3d 775 (9th Cir. 2015) (discusses hypothetical monopolist test in healthcare mergers)
- FTC v. H.J. Heinz Co., 246 F.3d 708 (D.C. Cir. 2001) (efficiencies defense requires merger‑specific, verifiable efficiencies)